Pharmaceutical & Healthcare Market Studies by BMI RESEARCH Now Available at

23 May 2016 • by Natalie Aster

LONDON – is very happy to inform that different countries’ pharmaceutical and healthcare market studies by BMI RESEARCH can now be found in its online catalogue.

In India, operating environment for multinational drugmakers remains tough. Little improvement is likely to take place over the medium term. Innovative firms are expected to adopt a cautious approach to the country.

However, the Czech Republic is one of the most attractive markets in the CEE region in terms of pharma and healthcare investment. Pharma sales are forecast to increase considerably in the years to come.

In Belgium, the pharmaceutical market is stable, and per capita spending on medicines is high. Denmark has a relatively small market for pharmaceuticals if compared to other Western European countries.

With per capita spending being high in this country, this marketplace is attractive for innovative drugmakers. Sales of high-value medicines are expected to grow in Denmark over a long term.

These research reports offer a comprehensive analysis of the pharmaceutical and healthcare marketplace in different countries. The studies contain insightful overviews of each marketplace.

They investigate performance of the healthcare sector and cover clinical trials in detail. The reports delve deep into the pharmaceutical distribution and pharmaceutical retail sector.

The research studies scrutinize the competitive environment in the countries and focus on top players. They comprise historical data and offer detailed market and industry forecasts for the years to come.

Countries Investigated in the Reports Include:

Companies mentioned in the research studies comprise: Merck & Co, Sanofi India, GlaxoSmithKline, Cipla, to name a few.

More new research reports by this publisher can be found at BMI RESEARCH page.


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970